New Topics in Pharmacy
See All >>1 Medivation and astellas announce submission of new drug application for enzalutamide for the treatment of castration-resistant prostate cancer in patients previously treated with chemotherapy Full Text Astellas, May 23, 2012
2 Not intended for U.S. and UK media -- Phase III MISSION Trial of Nexavar in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival Full Text BayNews International, May 23, 2012
3 Warfarin, aspirin similar in treating heart failure Full Text Drug Topics, May 23, 2012 Clinical Article
4 Study: Zithromax associated with cardiovascular deaths; FDA reviewing Full Text Drug Topics, May 23, 2012 Clinical Article
5 Emodin Regulates Apoptotic Pathway in Human Liver Cancer Cells Phytotherapy Research, May 23, 2012 Clinical Article
6 Influence on Effectiveness of Early Treatment with Anti-TNF Therapy in Rheumatoid Arthritis Full Text Journal of Pharmacy and Pharmaceutical Sciences, May 23, 2012 Clinical Article
7 Lack of a pharmacokinetic drug–drug interaction between lithium and valproate when co-administered with aripiprazole Journal of Clinical Pharmacy and Therapeutics, May 23, 2012 Clinical Article
8 Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial The Lancet Infectious Diseases, May 23, 2012 Clinical Article
9 Efficacy of pre-erythrocytic and blood-stage malaria vaccines can be assessed in small sporozoite challenge trials in human volunteers The Journal of Infectious Diseases, May 23, 2012 Clinical Article
10 Evaluation of the Impact of UGT Polymorphism on the Pharmacokinetics and Pharmacodynamics of the Novel PPAR Agonist Sipoglitazar The Journal of Clinical Pharmacology, May 23, 2012 Clinical Article
11 Use of Recreational Drug 1,3-Dimethylethylamine (DMAA) Associated With Cerebral Hemorrhage Annals of Emergency Medicine, May 23, 2012 Clinical Article
12 Its Important to Take Your Medication Everyday Okay? An Evaluation of Counselling by Lay Counsellors for ARV Adherence Support in the Western Cape, South Africa AIDS and Behavior, May 23, 2012
13 Statins associated with decreased risk of depressive symptoms Full Text Formulary , May 22, 2012 Clinical Article
14 High Platelet Reactivity on Clopidogrel Therapy Correlates With Increased Coronary Atherosclerosis and Calcification JACC - Journal of the American College of Cardiology: Cardiovascular Imaging, May 22, 2012 Clinical Article
15 FDA updates drospirenone-containing birth control pill labels to emphasize possible increased risk of blood clots in women Full Text Formulary , May 22, 2012 Clinical Article
16 Improving Long-Term ACS Management: Is There a Role for the New Antiplatelets Journal of Interventional Cardiology, May 22, 2012 Clinical Article
17 Summary of Ceftaroline Activity against Pathogens in the United States, 2010: Report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) Surveillance Program Antimicrobial Agents and Chemotherapy, May 22, 2012 Clinical Article
18 A Nucleoside- and Ritonavir-Sparing Regimen Containing Atazanavir Plus Raltegravir in Antiretroviral Treatment-Naïve HIV-Infected Patients: SPARTAN Study Results HIV Clinical Trials, May 22, 2012 Clinical Article
19 Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment Journal of Hypertension, May 22, 2012 Clinical Article
20 Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: A systematic review of contemporary randomized trials Lung Cancer, May 22, 2012 Evidence Based Medicine
Your Unread Messages in Pharmacy
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Daily physical activity reduces the risk of AD
1 Comparison of the safety, tolerability, and pharmacokinetic profile of a single oral dose of pitavastatin 4 mg in adult subjects with severe renal impairment not on hemodialysis versus healthy adult subjects Journal of Cardiovascular Pharmacology, April 6, 2012
2 Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease-A cost-effectiveness analysis BMC Cardiovascular Disorders, April 5, 2012
3 Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma—a long-term follow-up study Annals of Oncology, April 4, 2012
4 Interpretation of Point-of-care INR Results in Patients Treated with Dabigatran American Journal of Medicine, April 12, 2012
5 A multicenter prospective observational study of the conformity of temozolomide prescriptions in France Pharmacoepidemiology and Drug Safety, April 3, 2012
6 Randomized and double-blind controlled clinical trial of extracorporeal cardiac shock wave therapy for coronary heart disease Heart and Vessels, April 3, 2012
7 Successful treatment of acyclovir-resistant herpes simplex virus type 2 proctitis with leflunomide in an HIV-infected man Journal of Clinical Virology, April 6, 2012
8 Safety and efficacy of anisodamine on prevention of contrast induced nephropathy in patients with acute coronary syndrome Chinese Medical Journal, April 13, 2012 Free full text
9 Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial Annals of Internal Medicine, March 9, 2012
10 A screening study of drug-drug interactions in cerivastatin users: an adverse effect of clopidogrel Clinical Pharmacology & Therapeutics, April 2, 2012
11 An antibiotic that inhibits a late step in wall teichoic acid biosynthesis induces the cell wall stress stimulon in staphylococcus aureus Antimicrobial Agents and Chemotherapy, April 6, 2012
12 Dual effects of statins therapy in systemic lupus erythematosus and SLE-related atherosclerosis: The potential role for regulatory T cells Atherosclerosis, April 20, 2012
13 Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study International Journal of Geriatric Psychiatry, April 12, 2012
14 Alterations of oprd in carbapenem-intermediate and -susceptible strains of pseudomonas aeruginosa isolated from patients with bacteremia in a spanish multicenter study Antimicrobial Agents and Chemotherapy, April 6, 2012
15 Initiation of sulfonylureas versus metformin is associated with higher blood pressure at one year Pharmacoepidemiology and Drug Safety, April 6, 2012
16 Update on the role of antipsychotics in the treatment of Tourette syndrome Neuropsychiatric Disease and Treatment, April 2, 2012 Free full text
17 Results of phase I study of a multi-modality treatment for newly diagnosed glioblastoma multiforme using local implantation of concurrent BCNU wafers and permanent I-125 seeds followed by fractionated radiation and temozolomide chemotherapy Journal of Neuro-Oncology, April 9, 2012
18 A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis JACC - Journal of the American College of Cardiology, April 13, 2012
19 Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, April 6, 2012
20 An initial factor analysis of prominent aspects of health experiences for women with neck-shoulder pain Disability & Rehabilitation, April 13, 2012
Indexed Journals in Pharmacy: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close